Clinical trial
Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope
NCT05987670 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope
- Lead sponsor
- Imperial College London
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 25, 2023
- Completion date
- December 23, 2025
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, congestive heart failure, heart failure, heart failure with reduced ejection fraction, heart murmurs, heart valve diseases